0000950123-23-010860.txt : 20231114 0000950123-23-010860.hdr.sgml : 20231114 20231114160022 ACCESSION NUMBER: 0000950123-23-010860 CONFORMED SUBMISSION TYPE: 13F-NT PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230930 FILED AS OF DATE: 20231114 DATE AS OF CHANGE: 20231114 EFFECTIVENESS DATE: 20231114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BC SW, LP CENTRAL INDEX KEY: 0001786351 IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-NT SEC ACT: 1934 Act SEC FILE NUMBER: 028-20270 FILM NUMBER: 231405512 BUSINESS ADDRESS: STREET 1: 200 CLAREDON STREET CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6175162000 MAIL ADDRESS: STREET 1: 200 CLARENDON STREET CITY: BOSTON STATE: MA ZIP: 02116 13F-NT 1 primary_doc.xml X0202 13F-NT LIVE 0001786351 XXXXXXXX 09-30-2023 09-30-2023 false BC SW, LP

200 Clarendon Street Boston MA 02116

13F NOTICE 028-20270 28-18477 Bain Capital Life Sciences Investors, LLC Y The report on Form 13F for the period ended September 30, 2023 for BC SW, LP ("BC SW") is being filed by Bain Capital Life Sciences Investors, LLC, which is the general partner of BC SW. Adam Koppel 617-516-2000 /s/ Adam Koppel Boston MA 11-14-2023